For the first time in 30 years, a new drug class known as the CGRP-Antagonists (calcitonin gene-related peptide) has emerged. These medications are proving to be highly effective for migraine ...

Holding announced that it has received approval of a New Drug Submission, NDS, from the Health Canada’s Pharmaceutical Drugs ...

The global pain management drugs market was valued at $71,431.85 million in 2019, and is projected to reach $91,649.16 million by 2027, registering a CAGR of 3.8%. Rise in geriatric population is the ...

The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.

Countless saints and mystics have reported inexplicable messages from heaven, but scientists say there is an explanation ...

Fremanezumab is a calcitonin-gene related peptide (CGRP) pathway monoclonal antibody that is FDA approved for adults with ...

Before the headache even begins, your body may be sending strange, vivid warnings. Learn how to recognize and manage the ...

A once-a-day pill could transform the lives of migraine sufferers after it was given the green light for NHS use. The ...